CRVOCervoMed Inc.

CRVO Stock Price, Valuation & Chart | CervoMed Inc.

Compare

$2.640+0.07 (+2.72%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology CRVO intrinsic value CRVO calculated fair value vs price

Overview Financials Dividends Ratios

CRVO Historical price chart

CRVO Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization24.44M

PE Ratio-0.8

EPS-3.28

Trading Volume132.07K

Today's High/Low2.65/2.59

Dividend Yield0.00

52 Week High/Low10.89/2.13

Shares Outstanding9.26M

CRVO Financial Statement

CRVO Analyst ratings

CRVO Analysis & performance metrics

CRVO Company profile

CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases. It develops…

CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases. It develops neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, and brain stroke recovery. The company is based in Boston, Massachusetts.

CRVO Management team

Name

Position

Robert J. Cobuzzi Jr., Ph.D.COO

Chief Operating Officer & Director

John J. Alam M.D.CEO

Co-Founder, Chief Executive Officer, President & Director

Mark A. De Rosch Ph.D.

Executive Vice President of Regulatory, Government Affairs & Program Management

Kelly Blackburn M.H.A.

Executive Vice President of Clinical Development

Sylvie L. Gregoire Pharm.D.CTO

Co-Founder & Director

William Robert Elder J.D.CFO

Chief Financial Officer, General Counsel & Corporate Secretary

Claudia Ordonez M.D.

Senior Vice President of Medical Science

Name

Position

Robert J. Cobuzzi Jr., Ph.D.COO

Chief Operating Officer & Director

John J. Alam M.D.CEO

Co-Founder, Chief Executive Officer, President & Director

Mark A. De Rosch Ph.D.

Executive Vice President of Regulatory, Government Affairs & Program Management

Kelly Blackburn M.H.A.

Executive Vice President of Clinical Development

Sylvie L. Gregoire Pharm.D.CTO

Co-Founder & Director

William Robert Elder J.D.CFO

Chief Financial Officer, General Counsel & Corporate Secretary

Claudia Ordonez M.D.

Senior Vice President of Medical Science

Management Team

Robert J. Cobuzzi Jr., Ph.D.COO

Chief Operating Officer & Director

John J. Alam M.D.CEO

Co-Founder, Chief Executive Officer, President & Director

Mark A. De Rosch Ph.D.

Executive Vice President of Regulatory, Government Affairs & Program Management

Kelly Blackburn M.H.A.

Executive Vice President of Clinical Development

Sylvie L. Gregoire Pharm.D.CTO

Co-Founder & Director

William Robert Elder J.D.CFO

Chief Financial Officer, General Counsel & Corporate Secretary

Claudia Ordonez M.D.

Senior Vice President of Medical Science

Management

Robert J. Cobuzzi Jr., Ph.D.COO

Chief Operating Officer & Director

John J. Alam M.D.CEO

Co-Founder, Chief Executive Officer, President & Director

Mark A. De Rosch Ph.D.

Executive Vice President of Regulatory, Government Affairs & Program Management

Kelly Blackburn M.H.A.

Executive Vice President of Clinical Development

Sylvie L. Gregoire Pharm.D.CTO

Co-Founder & Director

William Robert Elder J.D.CFO

Chief Financial Officer, General Counsel & Corporate Secretary

Claudia Ordonez M.D.

Senior Vice President of Medical Science

Total 7 executives

CRVO Frequently asked questions

What is CervoMed Inc. (CRVO) Stock Price?

Current stock price of CervoMed Inc. (CRVO) stock is $2.640. The stock price is +2.72% higher in the session. The intraday range can be seen from this page. Volume of CervoMed Inc. (CRVO) stock is 132.07K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the CervoMed Inc. (CRVO) stock price going up or down today?

The stock price of CervoMed Inc. (CRVO) can change with earnings, company news, and overall market sentiment. CervoMed Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the CervoMed Inc. stock expensive at its current price?

Whether CervoMed Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for CRVO on this page is -0.80. EPS on this page is -3.28. Compare those figures with peers and growth expectations before deciding if the current CervoMed Inc. price is justified.

How has the stock price of CervoMed Inc. (CRVO) performed historically?

Historical performance for CervoMed Inc. (CRVO) is shown on the price chart on this page. Review multi-period moves alongside volume to see how CRVO reacted to past earnings and market events.

Should I buy CervoMed Inc. (CRVO) stock, at this price?

Buying CervoMed Inc. (CRVO) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.